IPO registrations (S-1, F-1) · Registrants
CapsoVision, Inc
- SEC CIK
- 1378325 · filings on EDGAR ↗
- Former names
- Capso Vision Inc (2006–2014)
- Registration
- Form S-1, first filed 2025-05-09, last 2026-04-17; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2025-07-03; declared effective 2025-07-01
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 18805 COX AVENUE SUITE 250, Saratoga, CA 95070
- EIN
- 20-3369494
- Ticker
- CV (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- CapsoVision, Inc on the corporate pages
Offering terms
- Proposed price range
- $5.00–$5.50 per share (S-1/A filed 2025-06-27)
- Final price
- $5.00 per share, within the range (424B4 filed 2025-07-03, an initial public offering)
- Shares sold
- 5,500,000
- Gross proceeds
- $27,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CV
- Lead underwriters
- The Benchmark Company; Roth Capital Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CAPSOVISION, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: CAPSO VISION INC EXACT (EIN (EXACT))
- Form D issuer: CapsoVision, Inc EXACT (CIK (EXACT))
- SEC filer: CapsoVision, Inc EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2025-05-09 | S-1 | S-1 (registration) | CapsoVision, Inc | 0001193125-25-116894 ↗ |
| 2025-05-30 | S-1/A | S-1/A (amendment) | CapsoVision, Inc | 0001193125-25-132293 ↗ |
| 2025-06-13 | S-1/A | S-1/A (amendment) | CapsoVision, Inc | 0001193125-25-140836 ↗ |
| 2025-06-27 | S-1/A | S-1/A (amendment) | CapsoVision, Inc | 0001193125-25-149285 ↗ |
| 2025-07-01 | EFFECT | EFFECT (declared effective) | CapsoVision, Inc | 9999999995-25-002126 ↗ |
| 2025-07-03 | 424B4 | 424B4 (final prospectus) | CapsoVision, Inc | 0001193125-25-155088 ↗ |
| 2026-04-17 | S-1 | S-1 (registration) | CapsoVision, Inc | 0001628280-26-025785 ↗ |
| 2026-04-22 | EFFECT | EFFECT (declared effective) | CapsoVision, Inc | 9999999995-26-001300 ↗ |
| 2026-08-21 | EFFECT | EFFECT (declared effective) | CapsoVision, Inc | 9999999995-26-002734 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-27 | S-1/A | registration statement | $5.00–$5.50 | 5,250,000 | - | Nasdaq CV | 2 | primary document; range, shares headline, cover names 2 | document ↗ | |
| 2025-07-03 | 424B4 | final prospectus | $5.00 | 5,500,000 | $27,500,000 | Nasdaq CV | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Atkinson Douglas Patrick | Officer | Head of Global Sales | 3 | 2025–2026 | |
| GOUW JULIA S | Director | 5 | 2025–2026 | ||
| Harari Michele | Director | 5 | 2025–2026 | ||
| Imperial Joanne Carol | Director | 6 | 2025–2026 | ||
| King Wen-Herng Henry | Director | 6 | 2025–2026 | ||
| Kuo Hui Ying | Director | 6 | 2025–2026 | ||
| Lundquist Kevin Michael | Officer | Chief Financial Officer | 1 | 2025 | |
| Petersen Rebecca Ann | Officer | Director of Clinical Affairs | 2 | 2025 | |
| Tsai Chen Lung | Director | 7 | 2025–2026 | ||
| Wang Kang-Huai | Director,Officer | See Remarks | 3 | 2025–2026 | |
| HARARI ELIYAHOU ET AL | TenPercentOwner | 8 | 2025–2026 | ||
| Garcia David Michael | Officer | Sr. VP of Finance | 3 | 2025–2026 | |
| Shen Ching Hang | TenPercentOwner | 4 | 2026 | ||
| Shields David Stanley | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-06-17 | CapsoVision, Inc | Biotechnology | $5,470,000 | $980,000 | 7 | 1 |
| 2019-11-26 | CapsoVision, Inc | Biotechnology | $64,828,840 | $64,828,822 | 114 | 5 |
| 2018-10-31 | CapsoVision, Inc | Biotechnology | $8,000,100 | $8,000,009 | 8 | 1 |
| 2018-10-31 | CapsoVision, Inc | Biotechnology | $10,000,000 | $6,058,958 | 11 | 1 |
| 2016-04-25 | CapsoVision, Inc | Biotechnology | $15,000,000 | $4,599,999 | 9 | 1 |
| 2014-02-21 | Capso Vision Inc | Biotechnology | $16,100,000 | $15,899,997 | 6 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CAPSOVISION, INC. | CA | State business registries | name and state |
| Form D issuer | CapsoVision, Inc | CA | Form D private offerings | CIK (EXACT) |
| Paying company | CapsoVision, Inc. | CA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | CAPSOVISION, INC. | CA | Patents (USPTO) | name and state |
| SEC filer | CapsoVision, Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | CapsoVision, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | CAPSO VISION INC | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, CA first:
- ENDOCARE INC CA
- IMAGYN MEDICAL INC CA
- CARDIAC PATHWAYS CORP CA
- ARADIGM CORP CA
- ORATEC INTERVENTIONS INC CA
- VNUS MEDICAL TECHNOLOGIES INC CA
- RITA MEDICAL SYSTEMS INC CA
- CURON MEDICAL INC CA
- CUTERA INC CA
- INTRALASE CORP CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology